Alx Oncology Holdings Inc. (ALXO)
NASDAQ · Healthcare
Alx Oncology Holdings Inc. Operating Income 2018–2022
Alx Oncology Holdings Inc. annual/quarterly operating income history and growth rate from 2018 to 2020. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Alx Oncology Holdings Inc. operating income for the quarter ending June 30, 2020 was -10.8 M, a 157.51% increase year-over-year.
- Alx Oncology Holdings Inc. operating income for the twelve months ending June 30, 2020 was -23.3 M.
- Alx Oncology Holdings Inc. annual operating income for 2022 was -127.4 M, a 52.52% increase from 2021.
- Alx Oncology Holdings Inc. annual operating income for 2021 was -83.6 M, a 91.36% increase from 2020.
- Alx Oncology Holdings Inc. annual operating income for 2020 was -43.7 M, a 127.61% increase from 2019.
- Alx Oncology Holdings Inc. annual operating income for 2019 was -19.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alx Oncology Holdings Inc. Operating Income — FAQ
Alx Oncology Holdings Inc. (ALXO) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Alx Oncology Holdings Inc.'s operating income?
Alx Oncology Holdings Inc. (ALXO) reported operating income of -$127M for fiscal 2022.
Where can I see ALXO's operating income history?
The chart and table above show Alx Oncology Holdings Inc.'s operating income by year and by quarter, including the growth rate.